Stock comparison
CONMED
CNMD$1.47BHealthcare Market cap, Sector
Pro Medicus Limited
PME.AX$18.4BHealthcare Market cap, Sector
Overall winner
Pro Medicus Limited
CNMD 07 PME.AX
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
CNMD0wins
7winsPME.AX
41F
B78
32F
A90
30F
A98
17F
A100
20F
B84
37F
A91
32F
A96
Side-by-side metrics
| Metric | CNMD | PME.AX |
|---|---|---|
| Market cap | $1.47B | $18.4B Winner |
| P/E (TTM) | Winner: 19.6x | 147.6x |
| EV/EBIT | Winner: 13.4x | 106.8x |
| ROIC (TTM) | 5.08% | 42.56% Winner |
| Gross margin | 53.58% | 99.85% Winner |
| Net margin | 4.0% | 54.12% Winner |
| Revenue CAGR 5y | 7.99% | 31.61% Winner |
| EPS CAGR 5y | -8.2% | 37.34% Winner |
| Debt / Equity | 0.8x | 0.0x Winner |
| Dividend yield | 1.14% | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
CNMD leads on
- EV/EBIT13.4xvs 106.8x+87%
- P/E (TTM)19.6xvs 147.6x+87%
PME.AX leads on
- EPS CAGR 5y37.34%vs -8.2%+122%
- Debt / Equity0.0xvs 0.8x+99%
- Net margin54.12%vs 4.0%+93%
- Market cap$18.4Bvs $1.47B+92%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.